S&P 500

6.032,38

0,56%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
Europa
EU
Innate Pharma (IPH)
Innate Pharma (IPH) Notícias

IPH

Innate Pharma (IPH)

Innate Pharma

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:EU:IPH

1 2 3 4 5 6 7 8 9 10 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
19/12/2023	09:38	MF Dow Jones (Italiano)	Le azioni di Innate Pharma salgono dopo l'esercizio dell'opzione dilicenza da parte di Sanofi	EU:IPH	Innate Pharma
19/12/2023	09:28	Dow Jones News	Innate Pharma Shares Rise after Sanofi Exercises Licensing Option	EU:IPH	Innate Pharma
19/12/2023	04:39	Dow Jones News	Sanofi exerce une option de licence en oncologie auprès d'Innate Pharma	EU:IPH	Innate Pharma
05/10/2023	09:14	Dow Jones News	Innate Pharma Shares Fall Premarket on FDA Partial Study Hold	EU:IPH	Innate Pharma
08/06/2023	11:53	Dow Jones News	Innate Pharma Shares Rise 8% After Cancer Treatment Gets Fast Track Designation	EU:IPH	Innate Pharma
19/12/2022	04:25	Dow Jones News	Sanofi et Innate Pharma étendent leur collaboration en oncologie avec les cellules NK	EU:IPH	Innate Pharma
01/08/2022	07:30	Dow Jones News	Innate Pharma Shares Slide After Failure of Monalizumab in Head, Neck Cancer	EU:IPH	Innate Pharma
23/09/2021	02:00	GlobeNewswire Inc.	Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er septembre 2021	EU:IPH	Innate Pharma
23/09/2021	02:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of September 1, 2021	EU:IPH	Innate Pharma
17/09/2021	08:45	GlobeNewswire Inc.	Monalizumab Data From COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
17/09/2021	08:45	GlobeNewswire Inc.	Présentation de Données Issues de l'Essai COAST Comprenant Monalizumab au Congrès de l'ESMO 2021	EU:IPH	Innate Pharma
17/09/2021	08:45	GlobeNewswire Inc.	Monalizumab Data from COAST Trial Presented at ESMO Congress 2021	EU:IPH	Innate Pharma
15/09/2021	02:00	GlobeNewswire Inc.	Innate Pharma reports first half 2021 financial results and business update	EU:IPH	Innate Pharma
15/09/2021	02:00	GlobeNewswire Inc.	Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au premier semestre 2021	EU:IPH	Innate Pharma
15/09/2021	02:00	GlobeNewswire Inc.	Rapport Financier Semestriel 30 juin 2021	EU:IPH	Innate Pharma
15/09/2021	02:00	GlobeNewswire Inc.	Innate Pharma Reports First Half 2021 Financial Results and Business Update	EU:IPH	Innate Pharma
07/09/2021	02:00	GlobeNewswire Inc.	Innate Pharma Organise une Conférence Téléphonique et un Webcast pour ses Résultats Financiers au Premier Semestre 2021	EU:IPH	Innate Pharma
07/09/2021	02:00	GlobeNewswire Inc.	Innate Pharma Announces Conference Call and Webcast for First Half 2021 Business Update	EU:IPH	Innate Pharma
02/09/2021	03:00	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will Be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
02/09/2021	03:00	GlobeNewswire Inc.	Des données sur monalizumab et ANKET™ seront présentées au congrès virtuel de l’ESMO 2021	EU:IPH	Innate Pharma
02/09/2021	03:00	GlobeNewswire Inc.	Monalizumab and ANKET™ Data Will be Presented at ESMO 2021 Virtual Congress	EU:IPH	Innate Pharma
30/08/2021	02:00	GlobeNewswire Inc.	Innate Pharma to Participate in Upcoming Investor Conferences	EU:IPH	Innate Pharma
30/08/2021	02:00	GlobeNewswire Inc.	Prochains Rendez-Vous Investisseurs d'Innate Pharma	EU:IPH	Innate Pharma
11/08/2021	02:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of August 1, 2021	EU:IPH	Innate Pharma
11/08/2021	02:00	GlobeNewswire Inc.	Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Aout 2021	EU:IPH	Innate Pharma
12/07/2021	02:00	GlobeNewswire Inc.	NUMBER OF SHARES AND VOTING RIGHTS OF INNATE PHARMA AS OF JULY 1, 2021	EU:IPH	Innate Pharma
12/07/2021	02:00	GlobeNewswire Inc.	Nouveau Nombre d'Actions et de Droits de Vote d'Innate Pharma au 1er Juillet 2021	EU:IPH	Innate Pharma
12/07/2021	02:00	GlobeNewswire Inc.	Number of Shares and Voting Rights of Innate Pharma as of July 1, 2021	EU:IPH	Innate Pharma
06/07/2021	02:00	GlobeNewswire Inc.	Update on Avdoralimab Phase 2 Force Trial in COVID-19 Patients With Severe Pneumonia	EU:IPH	Innate Pharma
06/07/2021	02:00	GlobeNewswire Inc.	Update on Avdoralimab Phase 2 FORCE Trial in COVID-19 Patients with Severe Pneumonia	EU:IPH	Innate Pharma